Irminger-Finger I - Search Results

1

Nuclear-cytoplasmic translocation of BARD1 is linked to its apoptotic activity.

Jefford CE, Feki A, Harb J, Krause KH, Irminger-Finger I. Jefford CE, et al. Oncogene. 2004 Apr 29;23(20):3509-20. doi: 10.1038/sj.onc.1207427. Oncogene. 2004. PMID: 15077185

2

Identification of BARD1 splice-isoforms involved in human trophoblast invasion.

Li L, Cohen M, Wu J, Sow MH, Nikolic B, Bischof P, Irminger-Finger I. Li L, et al. Int J Biochem Cell Biol. 2007;39(9):1659-72. doi: 10.1016/j.biocel.2007.04.018. Epub 2007 Apr 27. Int J Biochem Cell Biol. 2007. PMID: 17556008

3

BARD1 splice variants display mislocalization in breast cancer cells and can alter the apoptotic response to cisplatin.

Marzec KA, Martino-Echarri E, Irminger-Finger I, Henderson BR. Marzec KA, et al. Among authors: irminger finger i. Cancer Lett. 2016 Oct 10;381(1):149-55. doi: 10.1016/j.canlet.2016.07.034. Epub 2016 Jul 28. Cancer Lett. 2016. PMID: 27477900

4

BARD1 mediates TGF-β signaling in pulmonary fibrosis.

André PA, Prêle CM, Vierkotten S, Carnesecchi S, Donati Y, Chambers RC, Pache JC, Crestani B, Barazzone-Argiroffo C, Königshoff M, Laurent GJ, Irminger-Finger I. André PA, et al. Respir Res. 2015 Sep 29;16:118. doi: 10.1186/s12931-015-0278-3. Respir Res. 2015. PMID: 26415510 Free PMC article.

5

Analysis of large mutations in BARD1 in patients with breast and/or ovarian cancer: the Polish population as an example.

Klonowska K, Ratajska M, Czubak K, Kuzniacka A, Brozek I, Koczkowska M, Sniadecki M, Debniak J, Wydra D, Balut M, Stukan M, Zmienko A, Nowakowska B, Irminger-Finger I, Limon J, Kozlowski P. Klonowska K, et al. Sci Rep. 2015 May 21;5:10424. doi: 10.1038/srep10424. Sci Rep. 2015. PMID: 25994375 Free PMC article.

6

HDAC inhibitors repress BARD1 isoform expression in acute myeloid leukemia cells via activation of miR-19a and/or b.

Lepore I, Dell'Aversana C, Pilyugin M, Conte M, Nebbioso A, De Bellis F, Tambaro FP, Izzo T, Garcia-Manero G, Ferrara F, Irminger-Finger I, Altucci L. Lepore I, et al. PLoS One. 2013 Dec 11;8(12):e83018. doi: 10.1371/journal.pone.0083018. eCollection 2013. PLoS One. 2013. PMID: 24349422 Free PMC article.

7

BARD1: an independent predictor of survival in non-small cell lung cancer.

Zhang YQ, Bianco A, Malkinson AM, Leoni VP, Frau G, De Rosa N, André PA, Versace R, Boulvain M, Laurent GJ, Atzori L, Irminger-Finger I. Zhang YQ, et al. Int J Cancer. 2012 Jul 1;131(1):83-94. doi: 10.1002/ijc.26346. Epub 2011 Dec 21. Int J Cancer. 2012. PMID: 21815143

8

BARD1 serum autoantibodies for the detection of lung cancer.

Pilyugin M, Descloux P, André PA, Laszlo V, Dome B, Hegedus B, Sardy S, Janes S, Bianco A, Laurent GJ, Irminger-Finger I. Pilyugin M, et al. Among authors: irminger finger i. PLoS One. 2017 Aug 7;12(8):e0182356. doi: 10.1371/journal.pone.0182356. eCollection 2017. PLoS One. 2017. PMID: 28786985 Free PMC article.

9

Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity.

Bosse KR, Diskin SJ, Cole KA, Wood AC, Schnepp RW, Norris G, Nguyen le B, Jagannathan J, Laquaglia M, Winter C, Diamond M, Hou C, Attiyeh EF, Mosse YP, Pineros V, Dizin E, Zhang Y, Asgharzadeh S, Seeger RC, Capasso M, Pawel BR, Devoto M, Hakonarson H, Rappaport EF, Irminger-Finger I, Maris JM. Bosse KR, et al. Cancer Res. 2012 Apr 15;72(8):2068-78. doi: 10.1158/0008-5472.CAN-11-3703. Epub 2012 Feb 20. Cancer Res. 2012. PMID: 22350409 Free PMC article.

10

Oncogenic BARD1 isoforms expressed in gynecological cancers.

Li L, Ryser S, Dizin E, Pils D, Krainer M, Jefford CE, Bertoni F, Zeillinger R, Irminger-Finger I. Li L, et al. Cancer Res. 2007 Dec 15;67(24):11876-85. doi: 10.1158/0008-5472.CAN-07-2370. Cancer Res. 2007. PMID: 18089818

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results